Trials / Completed
CompletedNCT01603095
A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 363 (actual)
- Sponsor
- BioMarin Pharmaceutical · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter, multinational study to collect consistent baseline growth measurements on pediatric patients with Achondroplasia being considered for subsequent enrollment in future studies sponsored by BioMarin. No study drug is administered.
Conditions
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2021-02-01
- Completion
- 2021-02-01
- First posted
- 2012-05-22
- Last updated
- 2021-04-13
Locations
20 sites across 6 countries: United States, Australia, Japan, Spain, Turkey (Türkiye), United Kingdom
Source: ClinicalTrials.gov record NCT01603095. Inclusion in this directory is not an endorsement.